257 related articles for article (PubMed ID: 26940105)
1. Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study.
Patel R; Wilson R; Jackson R; Ball M; Shetty H; Broadbent M; Stewart R; McGuire P; Bhattacharyya S
BMJ Open; 2016 Mar; 6(3):e009888. PubMed ID: 26940105
[TBL] [Abstract][Full Text] [Related]
2. Mood instability is a common feature of mental health disorders and is associated with poor clinical outcomes.
Patel R; Lloyd T; Jackson R; Ball M; Shetty H; Broadbent M; Geddes JR; Stewart R; McGuire P; Taylor M
BMJ Open; 2015 May; 5(5):e007504. PubMed ID: 25998036
[TBL] [Abstract][Full Text] [Related]
3. Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis.
Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Murray R; Bhattacharyya S
Lancet Psychiatry; 2017 Aug; 4(8):627-633. PubMed ID: 28705600
[TBL] [Abstract][Full Text] [Related]
4. Cannabis use and treatment resistance in first episode psychosis: a natural language processing study.
Patel R; Wilson R; Jackson R; Ball M; Shetty H; Broadbent M; Stewart R; McGuire P; Bhattacharyya S
Lancet; 2015 Feb; 385 Suppl 1():S79. PubMed ID: 26312901
[TBL] [Abstract][Full Text] [Related]
5. Compulsory admission at first presentation to services for psychosis: does ethnicity still matter? Findings from two population-based studies of first episode psychosis.
Oduola S; Craig TKJ; Das-Munshi J; Bourque F; Gayer-Anderson C; Morgan C
Soc Psychiatry Psychiatr Epidemiol; 2019 Jul; 54(7):871-881. PubMed ID: 30895353
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic treatment failure in patients with psychosis and co-morbid cannabis use: A systematic review.
Reid S; Bhattacharyya S
Psychiatry Res; 2019 Oct; 280():112523. PubMed ID: 31450032
[TBL] [Abstract][Full Text] [Related]
7. Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study.
Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Ajnakina O; Gayer-Anderson C; Colizzi M; Quattrone D; Behlke I; Shetty S; McGuire P; David AS; Murray R; Bhattacharyya S
Lancet Psychiatry; 2016 Oct; 3(10):947-953. PubMed ID: 27567467
[TBL] [Abstract][Full Text] [Related]
8. Cannabis use and involuntary admission may mediate long-term adherence in first-episode psychosis patients: a prospective longitudinal study.
Barbeito S; Vega P; Ruiz de Azúa S; Saenz M; Martinez-Cengotitabengoa M; González-Ortega I; Bermudez C; Hernanz M; Corres BF; González-Pinto A
BMC Psychiatry; 2013 Dec; 13():326. PubMed ID: 24289797
[TBL] [Abstract][Full Text] [Related]
9. Unraveling ethnic disparities in antipsychotic prescribing among patients with psychosis: A retrospective cohort study based on electronic clinical records.
Wang T; Codling D; Bhugra D; Msosa Y; Broadbent M; Patel R; Roberts A; McGuire P; Stewart R; Dobson R; Harland R
Schizophr Res; 2023 Oct; 260():168-179. PubMed ID: 37669576
[TBL] [Abstract][Full Text] [Related]
10. Recorded poor insight as a predictor of service use outcomes: cohort study of patients with first-episode psychosis in a large mental healthcare database.
Ramu N; Kolliakou A; Sanyal J; Patel R; Stewart R
BMJ Open; 2019 Jun; 9(6):e028929. PubMed ID: 31196905
[TBL] [Abstract][Full Text] [Related]
11. Is paliperidone palmitate more effective than other long-acting injectable antipsychotics?
Patel R; Chesney E; Taylor M; Taylor D; McGuire P
Psychol Med; 2018 Jul; 48(10):1616-1623. PubMed ID: 29039277
[TBL] [Abstract][Full Text] [Related]
12. The relapse rate and predictors of relapse in patients with first-episode psychosis following discontinuation of antipsychotic medication.
Di Capite S; Upthegrove R; Mallikarjun P
Early Interv Psychiatry; 2018 Oct; 12(5):893-899. PubMed ID: 27734591
[TBL] [Abstract][Full Text] [Related]
13. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study.
Di Forti M; Marconi A; Carra E; Fraietta S; Trotta A; Bonomo M; Bianconi F; Gardner-Sood P; O'Connor J; Russo M; Stilo SA; Marques TR; Mondelli V; Dazzan P; Pariante C; David AS; Gaughran F; Atakan Z; Iyegbe C; Powell J; Morgan C; Lynskey M; Murray RM
Lancet Psychiatry; 2015 Mar; 2(3):233-8. PubMed ID: 26359901
[TBL] [Abstract][Full Text] [Related]
14. Differences in cannabis-related experiences between patients with a first episode of psychosis and controls.
Bianconi F; Bonomo M; Marconi A; Kolliakou A; Stilo SA; Iyegbe C; Gurillo Muñoz P; Homayoun S; Mondelli V; Luzi S; Dazzan P; Prata D; La Cascia C; O'Connor J; David A; Morgan C; Murray RM; Lynskey M; Di Forti M
Psychol Med; 2016 Apr; 46(5):995-1003. PubMed ID: 26670601
[TBL] [Abstract][Full Text] [Related]
15. Cannabis use and nonuse in patients with first-episode psychosis: A systematic review and meta-analysis of studies comparing neurocognitive functioning.
Sánchez-Gutiérrez T; Fernandez-Castilla B; Barbeito S; González-Pinto A; Becerra-García JA; Calvo A
Eur Psychiatry; 2020 Jan; 63(1):e6. PubMed ID: 32093788
[TBL] [Abstract][Full Text] [Related]
16. Impact of tobacco, alcohol and cannabis use on treatment outcomes among patients experiencing first episode psychosis: Data from the national RAISE-ETP study.
Oluwoye O; Monroe-DeVita M; Burduli E; Chwastiak L; McPherson S; McClellan JM; McDonell MG
Early Interv Psychiatry; 2019 Feb; 13(1):142-146. PubMed ID: 29356438
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic efficacy in psychosis with co-morbid cannabis misuse: A systematic review.
Wilson RP; Bhattacharyya S
J Psychopharmacol; 2016 Feb; 30(2):99-111. PubMed ID: 26510450
[TBL] [Abstract][Full Text] [Related]
18. Association of Hippocampal Atrophy With Duration of Untreated Psychosis and Molecular Biomarkers During Initial Antipsychotic Treatment of First-Episode Psychosis.
Goff DC; Zeng B; Ardekani BA; Diminich ED; Tang Y; Fan X; Galatzer-Levy I; Li C; Troxel AB; Wang J
JAMA Psychiatry; 2018 Apr; 75(4):370-378. PubMed ID: 29466532
[TBL] [Abstract][Full Text] [Related]
19. Negative Symptoms in Early-Onset Psychosis and Their Association With Antipsychotic Treatment Failure.
Downs J; Dean H; Lechler S; Sears N; Patel R; Shetty H; Hotopf M; Ford T; Kyriakopoulos M; Diaz-Caneja CM; Arango C; MacCabe JH; Hayes RD; Pina-Camacho L
Schizophr Bull; 2019 Jan; 45(1):69-79. PubMed ID: 29370404
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome in people with a psychotic illness: is cannabis protective?
Waterreus A; Di Prinzio P; Watts GF; Castle D; Galletly C; Morgan VA
Psychol Med; 2016 Jun; 46(8):1651-62. PubMed ID: 26965714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
